Mary Stawicki
Advertisement
Associate Director, regulatory affairs biopharm CMC, at GlaxoSmithKline
Articles by Mary Stawicki
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
2
Establishing Risk Assessments for AI in Bio-Manufacturing
3
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
4
Particle Risk Mitigation in Biomanucturing
5
